Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
Polyclonal free light chains: promising new biomarkers in inflammatory | CBF
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect
Light chain amyloidosis pathology. Clonal expansion of plasma cells... | Download Scientific Diagram
Kappa and Lambda Light Chains
Approaches for the generation of bispecific IgG based on light-chain... | Download Scientific Diagram
Free Light Chains as a Novel Diagnostic Biomarker of Immune System Abnormalities in Multiple Sclerosis and HIV Infection
Two cases of multiple myeloma, presenting with light-chain tubulopathy
Biomedicines | Free Full-Text | Immunoglobulins or Antibodies: IMGT® Bridging Genes, Structures and Functions | HTML
Case 966-- Clinical Chemistry Case
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies | Hematology, Transfusion and Cell Therapy
Cast Nephropathy and Deceptively Low Absolute Serum Free Light Chain Levels: Resolution of a Challenging Case and Systematic Review of the Literature - Clinical Lymphoma, Myeloma and Leukemia
A Fresh Perspective on Monoclonal Gammopathies of Renal Significance - Kidney International Reports
The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases - ScienceDirect
immunoglobulin and free light chain (FLC) structure. immunoglobulins... | Download Scientific Diagram
Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?
Full article: Comparing domain interactions within antibody Fabs with kappa and lambda light chains
Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All | HTML
IgG Kappa Light Chain antibody (14678-1-AP) | Proteintech
SciELO - Brasil - Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies Serum free light chain assays not total light chain
The biology of immunoglobulin free light chains and kidney injury - Kidney International
Management of Monoclonal Gammopathy of Uncertain Significance | SpringerLink
Light chain only variant of proliferative glomerulonephritis with monoclonal immunoglobulin deposits is associated with a high detection rate of the pathogenic plasma cell clone - Kidney International
Characterization and Monitoring of a Novel Light-heavy-light Chain Mispair in a Therapeutic Bispecific Antibody - Journal of Pharmaceutical Sciences
Monoclonal Gammopathy of Renal Significance Causes C3 Glomerulonephritis Via Monoclonal IgG Kappa Inhibition of Complement Factor H - Kidney International Reports
Antibodies gone bad – the molecular mechanism of light chain amyloidosis - Absmeier - The FEBS Journal - Wiley Online Library
